If you need more lookups,
subscriptions start at $34 USD/month.
Zhou Jiang Location
Boston, MA, US
Zhou Jiang Work
Vice President of Early Commercial and Corporate Strategy @ (October 2022 - Present)
Senior Director Global Strategy Lead- Myasthenia Gravis @ (January 2022 - October 2022)
Director, Kalydeco, Orkambi, Symdeko and Symkevi+Kalydeco Global Brand Lead @ (January 2020 - January 2022)
Director, Orkambi Global Brand Lead @ (March 2018 - December 2019)
Associate Director, New Products @ (June 2015 - March 2018)
Senior Manager, New Products @ (December 2014 - May 2015)
Senior Product Manager, US Marketing aHUS @ (October 2012 - November 2014)
Medical Science Liaison @ (March 2010 - October 2012)
Territory Business Manager @ (July 2007 - March 2010)
Baraclude Global Marketing Post Pharm D. Fellow @ Rutgers University (September 2006 - June 2007)
Intern @ ImClone Systems, a wholly-owned subsidiary of Eli Lilly and Company (January 2004 - December 2004)
Zhou Jiang Education
NYU Stern School of Business
MBA, Business
2009-2012
Rutgers University
Pharm D., Pharmacy
2000-2006
Zhou Jiang Skills
Infectious Diseases
Quantitative Analysis
Product Development
Forecasting
PowerPoint
Business Development
Pharmaceutical Industry
Pharmaceuticals
Commercial Assessment
Social Media
Corporate Finance
Strategic Planning
Project Evaluation
Brand Development
Strategy
Sales
Market Planning
Microsoft Excel
Public Speaking
Teaching
Molecular Biology
Zhou Jiang Summary
Zhou Jiang, based in Boston, MA, US, is currently a Vice President of Early Commercial and Corporate Strategy at Edgewise Therapeutics. Zhou Jiang brings experience from previous roles at UCB, Vertex Pharmaceuticals and Alexion Pharmaceuticals, Inc.. Zhou Jiang holds a 2009 - 2012 MBA, Business @ NYU Stern School of Business. With a robust skill set that includes Infectious Diseases, Quantitative Analysis, Product Development, Forecasting, PowerPoint and more. Zhou Jiang has 2 emails and 1 mobile phone numbers on RocketReach.
Looking for a different Zhou Jiang?
Find contact details for 700 million professionals.